| Value | ₹2.63 Cr |
|---|
BSE filing, NSE: PHARMAID. Summary written from the filing by ALFA Finder's alert engine.
Pharmaids Pharmaceuticals Ltd: key numbers
- Share price
- ₹27.52
- Market cap
- ₹97.06 Cr
- Revenue (annual)
- ₹27.88 Cr
- Net profit (annual)
- ₹-11.72 Cr
- P/E (TTM)
- -21.3×Sector 46.1×
- Promoter holding
- 32.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pharmaids Pharmaceuticals Ltd
All →Pharmaids Pharmaceuticals Other Announcement
Pharmaids Pharmaceuticals Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent confirming the dematerialization of shares.
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals held its 37th AGM via video conference on 11 Sept 2026. Four resolutions including adoption of FY26 financials and related-party-transaction approvals were tabled.
Pharmaids Pharmaceuticals Promoter Buying (Off-Market)
KMP Prasanna Subramanya Bhat acquired 17,291 shares of Pharmaids Pharmaceuticals Ltd via a gift from an immediate relative. This off-market transfer is an insider disclosure.
- Promoter stake change
- +0.04%
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals Limited has issued the notice for its 37th Annual General Meeting, scheduled for September 11, 2026, along with the Annual Report for 2025-26.
Pharmaids Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.9 Cr, Down 64.2% YoY
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.9 Cr · -64.2% YoY
Pharmaids Pharmaceuticals Board Meeting Date
Pharmaids Pharmaceuticals scheduled a board meeting for August 12, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
Other legal & regulatory announcements
All →Coromandel International Legal & Regulatory
Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.
- Value
- ₹0.18 Cr
Taurian Mps Legal & Regulatory
Taurian MPS received a SEBI adjudication order imposing penalties of Rs.5 lakh on the company, Rs.5 lakh on promoters jointly, and Rs.8 lakh on the merchant banker. The penalties relate to IPO offer document disclosure deficiencies.
- Value
- ₹0.05 Cr
Coromandel International Legal & Regulatory
Coromandel International received a GST Order-in-Appeal confirming a ₹1.79 Crore tax demand. Including interest and penalty, the total is ₹4.05 Crore; the company will appeal.
- Value
- ₹4.05 Cr
Shreeji Global FMCG Legal & Regulatory
Shreeji Global FMCG received a customs Order-in-Original demanding about ₹42.47 Crore in duty, penalties and redemption fines. The company plans to appeal before CESTAT.
- Value
- ₹42.47 Cr
HD Fire Protect Legal & Regulatory
HD Fire Protect received an MPCB refusal of Consent to Operate for its Jalgaon expansion sheds. Existing manufacturing operations continue, with no material impact anticipated.
Krishna Institute of Medical Sciences Legal & Regulatory
KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.